CoChat

Multiple conserved regulatory domains promote Fezf2 expression in the developing cerebral cortex

Open access

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The genetic programs required for development of the cerebral cortex are under intense investigation. However, non-coding DNA elements that control the expression of developmentally important genes remain poorly defined. Here we investigate the regulation of Fezf2, a transcription factor that is necessary for the generation of deep-layer cortical projection neurons. RESULTS: Using a combination of chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) we mapped the binding of four deep-layer-enriched transcription factors previously shown to be important for cortical development. Building upon this we characterized the activity of three regulatory regions around the Fezf2 locus at multiple stages throughout corticogenesis. We identified a promoter that was sufficient for expression in the cerebral cortex, and enhancers that drove reporter gene expression in distinct forebrain domains, including progenitor cells and cortical projection neurons. CONCLUSIONS: These results provide insight into the regulatory logic controlling Fezf2 expression and further the understanding of how multiple non-coding regulatory domains can collaborate to control gene expression in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1749-8104-9-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Fezf2 is dynamically expressed during cortical development. In situ hybridization at E12.5 (A-A’), E15.5 (B-B’), and P0 (C-C’) for Fezf2 reveals its expression pattern during development. Ctx, cortex; LGE, lateral ganglionic eminence; LV, lateral ventricle; MGE, medial ganglionic eminence; PP, preplate; Str, striatum; VZ, ventricular zone. Scale bars: (A) 100 μm, (A’) 10 μm, (B) 250 μm, (B’) 25 μm, (C) 500 μm, (C’) 50 μm.
Figure 1 Fezf2 is dynamically expressed during cortical development. In situ hybridization at E12.5 (A-A’), E15.5 (B-B’), and P0 (C-C’) for Fezf2 reveals its expression pattern during development. Ctx, cortex; LGE, lateral ganglionic eminence; LV, lateral ventricle; MGE, medial ganglionic eminence; PP, preplate; Str, striatum; VZ, ventricular zone. Scale bars: (A) 100 μm, (A’) 10 μm, (B) 250 μm, (B’) 25 μm, (C) 500 μm, (C’) 50 μm.CC BY · PubMed Central
Figure 2 Mapping of transcription factor binding around the Fezf2 locus. (A) Diagram of the Fezf2 locus indicating positions of the 2.7 kb promoter and the putative enhancers 434, and 1316. (B, C) ChIP-seq was used to map the binding of transcription factors around the Fezf2 locus. (B) An overview of binding around enhancer 434 and the upstream conserved region. (C) An overview of factor binding around enhancer 1316. (B, C) Peaks called by MACS are highlighted in grey.
Figure 2 Mapping of transcription factor binding around the Fezf2 locus. (A) Diagram of the Fezf2 locus indicating positions of the 2.7 kb promoter and the putative enhancers 434, and 1316. (B, C) ChIP-seq was used to map the binding of transcription factors around the Fezf2 locus. (B) An overview of binding around enhancer 434 and the upstream conserved region. (C) An overview of factor binding around enhancer 1316. (B, C) Peaks called by MACS are highlighted in grey.CC BY · PubMed Central
Figure 3 Promoter activity of the 2.7 kb fragment during cortical development. (A) X-Gal staining at E11.5 revealed reporter activity in the cerebral cortex, similar to endogenous Fezf2 expression. (B-D) Immunohistochemistry with ß-Gal antibody combined with SOX2 (B), Tuj1 (C), and TBR1 (D) antibodies. (E) Whole mount X-Gal staining of P0 brains demonstrating expression in the forebrain. (F) X-Gal staining of P0 brain sections. (G-I’) Immunohistochemistry using ß-Gal antibody combined with antibodies for SOX2 (G, G’), CTIP2 (H, H’) and SATB2 (I, I’). Arrows represent co-expression of LacZ and the indicated markers. Arrowheads indicate a lack of co-expression. PP, preplate. Scale bars: (A) 200 μm, (D) 50 μm, (E) 250 mm, (F) 500 μm, (I) 100 μm, (I’) 50 μm.
Figure 3 Promoter activity of the 2.7 kb fragment during cortical development. (A) X-Gal staining at E11.5 revealed reporter activity in the cerebral cortex, similar to endogenous Fezf2 expression. (B-D) Immunohistochemistry with ß-Gal antibody combined with SOX2 (B), Tuj1 (C), and TBR1 (D) antibodies. (E) Whole mount X-Gal staining of P0 brains demonstrating expression in the forebrain. (F) X-Gal staining of P0 brain sections. (G-I’) Immunohistochemistry using ß-Gal antibody combined with antibodies for SOX2 (G, G’), CTIP2 (H, H’) and SATB2 (I, I’). Arrows represent co-expression of LacZ and the indicated markers. Arrowheads indicate a lack of co-expression. PP, preplate. Scale bars: (A) 200 μm, (D) 50 μm, (E) 250 mm, (F) 500 μm, (I) 100 μm, (I’) 50 μm.CC BY · PubMed Central
Figure 4 Enhancer 434 is active in cortical progenitor cells. (A-C) Immunohistochemistry demonstrated LacZ expression in progenitor cells at E11.5 that co-expressed SOX2 (A), PAX6 (B) and PHH3 (C). LacZ was also expressed in a few postmitotic neurons in the preplate marked by Tuj1 (D). X-Gal staining of whole mount P0 brains (E) and sections (F) demonstrated reporter activity in the VZ. (G, H) Immunohistochemistry using ß-Gal antibody combined with antibodies for RGC markers BLBP (G) and PAX6 (H). (I, K, L) In adult animals, the majority of enhancer 434-LacZ+ cells were in GFAP+ astrocytes throughout the forebrain. A subset of non-astrocyte like cells expressed SATB2 (J, J’). Arrows represent co-expression of LacZ and the indicated markers. Hip, hippocampus; WM, white matter. Scale bars: (D) 50 μm, (E) 250 mm, (F) 500 μm, (G) 25 μm, (H) 10 μm, (I) 500 μm, (J) 100 μm, (J’) 50 μm, (K) 25 μm.
Figure 4 Enhancer 434 is active in cortical progenitor cells. (A-C) Immunohistochemistry demonstrated LacZ expression in progenitor cells at E11.5 that co-expressed SOX2 (A), PAX6 (B) and PHH3 (C). LacZ was also expressed in a few postmitotic neurons in the preplate marked by Tuj1 (D). X-Gal staining of whole mount P0 brains (E) and sections (F) demonstrated reporter activity in the VZ. (G, H) Immunohistochemistry using ß-Gal antibody combined with antibodies for RGC markers BLBP (G) and PAX6 (H). (I, K, L) In adult animals, the majority of enhancer 434-LacZ+ cells were in GFAP+ astrocytes throughout the forebrain. A subset of non-astrocyte like cells expressed SATB2 (J, J’). Arrows represent co-expression of LacZ and the indicated markers. Hip, hippocampus; WM, white matter. Scale bars: (D) 50 μm, (E) 250 mm, (F) 500 μm, (G) 25 μm, (H) 10 μm, (I) 500 μm, (J) 100 μm, (J’) 50 μm, (K) 25 μm.CC BY · PubMed Central
Figure 5 Enhancer 1316 is active in deep-layer cortical neurons. (A-D) Immunohistochemical analysis of E11.5 brain sections using antibodies for ß-Gal (A), ß-Gal and PAX6 (B), ß-Gal and SOX2 (C), and ß-Gal and Tuj1 (D). (E, F) X-Gal staining of P0 whole mount brains (E) and brain sections (F). (G-I) Immunohistochemistry using ß-Gal antibody combined with antibodies for SOX2 (G), CTIP2 (H), and SATB2 (I). Arrows represent co-expression of LacZ and the indicated markers. Arrowheads indicate a lack of co-expression. Scale bars: (A) 200 μm, (D) 50 μm, (E) 250 mm, (F) 500 μm, (I) 100 μm, (I’) 25 μm.
Figure 5 Enhancer 1316 is active in deep-layer cortical neurons. (A-D) Immunohistochemical analysis of E11.5 brain sections using antibodies for ß-Gal (A), ß-Gal and PAX6 (B), ß-Gal and SOX2 (C), and ß-Gal and Tuj1 (D). (E, F) X-Gal staining of P0 whole mount brains (E) and brain sections (F). (G-I) Immunohistochemistry using ß-Gal antibody combined with antibodies for SOX2 (G), CTIP2 (H), and SATB2 (I). Arrows represent co-expression of LacZ and the indicated markers. Arrowheads indicate a lack of co-expression. Scale bars: (A) 200 μm, (D) 50 μm, (E) 250 mm, (F) 500 μm, (I) 100 μm, (I’) 25 μm.CC BY · PubMed Central
Figure 6 A model for the regulation of Fezf2 transcription in the cortex. The 2.7 kb promoter was sufficient to drive transcription across all endogenous Fezf2 expression domains throughout development of the cerebral cortex. Enhancer 434 exhibited strongest activity in cortical progenitor cells and in contrast enhancer 1316 was strictly active in deep-layer postmitotic neurons.
Figure 6 A model for the regulation of Fezf2 transcription in the cortex. The 2.7 kb promoter was sufficient to drive transcription across all endogenous Fezf2 expression domains throughout development of the cerebral cortex. Enhancer 434 exhibited strongest activity in cortical progenitor cells and in contrast enhancer 1316 was strictly active in deep-layer postmitotic neurons.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 29

Metadata

Authors
Eckler, M. J., Larkin, K. A., McKenna, W. L., Katzman, S., Guo, C., Roque, R., Visel, A., Rubenstein, J. L. L., & Chen, B.
Affiliations
  • University of California, Santa Cruz (US)
  • Lawrence Berkeley National Laboratory (US)
Corresponding author
Chen, Bin
Venue
Neural Development
Published
2014-03-12
Volume
9
Issue
1
Pages
6-6
ISSN
1749-8104 (ISSN-L)
OpenAlex
W2153518972
Cited by
27
References
50
Citations by year
2025: 1 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 1 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 2
FWCI
1.27
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neural Development (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • California Institute of Regenerative Medicine
  • National Institute of Mental Health (R01MH094589)
  • National Human Genome Research Institute (R01HG003988)
  • National Institute of Neurological Disorders and Stroke (R01NS062859, R01 NS062859A, NS34661, R01NS034661, R01NS099099)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
Fezf2, cortical development, transcription factor binding sites, enhancers, promoter, non-coding regulatory elements, cortical progenitor cells, forebrain, gene expression regulation
MeSH terms
Animals, Cerebral Cortex, DNA-Binding Proteins, Enhancer Elements, Genetic, Mice, Transgenic, Nerve Tissue Proteins, Regulatory Elements, Transcriptional, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple conserved regulatory domains promote Fezf2 expression in the developing cerebral cortex. https://app.cochat.ai/papers/10.1186/1749-8104-9-6
The paper
Eckler, M. J., Larkin, K. A., McKenna, W. L., Katzman, S., Guo, C., Roque, R., Visel, A., Rubenstein, J. L. L., & Chen, B. (2014). Multiple conserved regulatory domains promote Fezf2 expression in the developing cerebral cortex. Neural Development. https://doi.org/10.1186/1749-8104-9-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.